Meftal Tablets

MEFTAL-SPAS® Drops

MEFTAL-SPAS® Drops is a paediatric antispasmodic and antiflatulent formulation indicated for the symptomatic relief of infantile and childhood colic, abdominal cramps, and gas-related discomfort.

Clinical Applications

Infantile Colic

Infantile Colic

Learn More
Abdominal Cramps

Abdominal Cramps

Learn More
Flatulence & Bloating

Flatulence & Bloating

Learn More
Paediatric IBS

Paediatric IBS

Learn More

More Clinical Application

  • Neonatology: Post-feed discomfort and gripe-related crying episodes in infants above six months.

Prescribing Guidelines by Age

MEFTAL-SPAS® product range is formulated to provide age-appropriate dosing across the patient lifecycle. While Drops are the preferred delivery system for infants and young children, the brand offers alternate formats for older age groups.

Patient Age Group Recommended Format Typical Clinical Use
Infants (up to 6 months) Not recommended Consult paediatrician for gripe- and colic-related discomfort.
Infants & Children:
6 - 12 months: Drops
Above 12 months: Suspension 		Drops/Suspension Infantile colic, abdominal cramps, and gas-related bloating.
Adolescents (12+ years) Suspension
  • Monthly period pain and functional GI spasms.
  • Biliary, Renal, and Intestinal colic.
Adults Tablet
  • Monthly period pain and functional GI spasms.
  • Biliary, Renal, and Intestinal colic.
Adults (Emergency Care) Injection Severe, sudden spasms requiring rapid onset.

Pharmacological Highlights for the Physician

  • Dual Mechanism
    Combines the antispasmodic effect of Dicyclomine Hydrochloride (to relax intestinal smooth muscle) with the antiflatulent effect of Simethicone (to disperse trapped gas).
  • Paediatric-Friendly Design
    Special Calibrated dropper for precise, low-volume dosing suited to infants and young children.

Prescribing Information

Generic Name

Dicyclomine Hydrochloride & Simethicone Suspension

(Brand Name: MEFTAL-SPAS® Drops)

Qualitative and Quantitative Composition

MEFTAL-SPAS®; Drops

Each ml contains:

Dicyclomine Hydrochloride IP - 10 mg

Simethicone IP -40 mg

Dosage Form and Strength

Dosage Form: Oral drops.

Dosage Strength: Dicyclomine hydrochloride 10 mg + Simethicone 40 mg per 5 ml.

Posology and Method of Administration

For oral administration in infants and young children, using the calibrated dropper provided.

  • MEFTAL-SPAS® Drops

    0.5 to 1 ml to be administered three to four times daily or as prescribed by the physician.

Not recommended for infants below six months of age unless specifically advised by a paediatrician. Shake well before use and administer with or without food. Or, as prescribed by the physician.

Contraindications

MEFTAL-SPAS® Drops are contraindicated in the following

  • Known hypersensitivity to dicyclomine or simethicone or to any component of the formulation.
  • Infants below six months of age.
  • Obstructive or inflammatory bowel disease, paralytic ileus, and intestinal atony.
  • Glaucoma.
  • Myasthenia gravis.
  • Urinary retention or obstructive uropathy.
  • Unstable cardiovascular status.

Possible Side Effects (Safety Information)

For detailed quantitative and qualitative composition, therapeutic indications, posology and method of administration, contraindications, special warnings and precautions for use, drug interactions, undesirable effects, overdose, mechanism of action, and pharmacodynamic properties of MEFTAL-SPAS® Drops, download the note.